TY - JOUR
T1 - Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic
T2 - the THOCOoP cooperative group
AU - Arrieta, Oscar
AU - Cardona, Andrés F.
AU - Lara-Mejía, Luis
AU - Heredia, David
AU - Barrón, Feliciano
AU - Zatarain-Barrón, Zyanya Lucia
AU - Lozano, Francisco
AU - de Lima, Vladmir Cordeiro
AU - Maldonado, Federico
AU - Corona-Cruz, Francisco
AU - Ramos, Maritza
AU - Cabrera, Luis
AU - Martin, Claudio
AU - Corrales, Luis
AU - Cuello, Mauricio
AU - Arroyo-Hernández, Marisol
AU - Aman, Enrique
AU - Bacon, Ludwing
AU - Baez, Renata
AU - Benitez, Sergio
AU - Botero, Antonio
AU - Burotto, Mauricio
AU - Caglevic, Christian
AU - Ferraris, Gustavo
AU - Freitas, Helano
AU - Kaen, Diego Lucas
AU - Lamot, Sebastián
AU - Lyons, Gustavo
AU - Mas, Luis
AU - Mata, Andrea
AU - Mathias, Clarissa
AU - Muñoz, Alvaro
AU - Patane, Ana Karina
AU - Oblitas, George
AU - Pino, Luis
AU - Raez, Luis E.
AU - Remon, Jordi
AU - Rojas, Leonardo
AU - Rolfo, Christian
AU - Ruiz-Patiño, Alejandro
AU - Samtani, Suraj
AU - Viola, Lucia
AU - Viteri, Santiago
AU - Rosell, Rafael
N1 - Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - The world currently faces a pandemic due to SARS-CoV-2. Relevant information has emerged regarding the higher risk of poor outcomes in lung cancer patients. As such, lung cancer patients must be prioritized in terms of prevention, detection and treatment. On May 7th, 45 experts in thoracic cancers from 11 different countries were invited to participate. A core panel of experts regarding thoracic oncology care amidst the pandemic gathered virtually, and a total of 60 initial recommendations were drafted based on available evidence, 2 questions were deleted due to conflicting evidence. By May 16th, 44 experts had agreed to participate, and voted on each of the 58 recommendation using a Delphi panel on a live voting event. Consensus was reached regarding the recommendations (>66 % strongly agree/agree) for 56 questions. Strong consensus (>80 % strongly agree/agree) was reached for 44 questions. Patients with lung cancer represent a particularly vulnerable population during this time. Special care must be taken to maintain treatment while avoiding exposure.
AB - The world currently faces a pandemic due to SARS-CoV-2. Relevant information has emerged regarding the higher risk of poor outcomes in lung cancer patients. As such, lung cancer patients must be prioritized in terms of prevention, detection and treatment. On May 7th, 45 experts in thoracic cancers from 11 different countries were invited to participate. A core panel of experts regarding thoracic oncology care amidst the pandemic gathered virtually, and a total of 60 initial recommendations were drafted based on available evidence, 2 questions were deleted due to conflicting evidence. By May 16th, 44 experts had agreed to participate, and voted on each of the 58 recommendation using a Delphi panel on a live voting event. Consensus was reached regarding the recommendations (>66 % strongly agree/agree) for 56 questions. Strong consensus (>80 % strongly agree/agree) was reached for 44 questions. Patients with lung cancer represent a particularly vulnerable population during this time. Special care must be taken to maintain treatment while avoiding exposure.
KW - COVID-19
KW - Health systems
KW - Lung cancer
KW - Personal protective equipment
KW - Recommendations
KW - Thoracic oncology
UR - http://www.scopus.com/inward/record.url?scp=85087481311&partnerID=8YFLogxK
U2 - 10.1016/j.critrevonc.2020.103033
DO - 10.1016/j.critrevonc.2020.103033
M3 - Review article
C2 - 32650215
AN - SCOPUS:85087481311
SN - 1040-8428
VL - 153
JO - Critical Reviews in Oncology/Hematology
JF - Critical Reviews in Oncology/Hematology
M1 - 103033
ER -